Jennifer Zhe Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jennifer Zhe Zhang has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Charles Weijer
Department of Medicine, Western University, London, Canada
2 shared publications - Hayden Peter Nix
Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada
2 shared publications - Monica Taljaard
Methodological and Implementation Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada
2 shared publications Spencer Phillips Hey
Center for Bioethics, Harvard Medical School, Boston, Massachusetts, USA
2 shared publicationsCory E Goldstein
Philosophy, Rotman Institute of Philosophy, London, Ontario, Canada
1 shared publicationDean A Fergusson
School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada
1 shared publication
Latest Publications
- Open Access
- 15 November 2021
- Published by BMJ in Journal of Medical Ethics
- Vol. 49 (1) , 34-40
Informed consent in pragmatic trials: results from a survey of trials published 2014–2019
Objectives To describe reporting of informed consent in pragmatic trials, justifications for waivers of consent and reporting of alternative approaches to standard written consent. To identify factors associated with (1) not reporting and (2) not obtaining consent. Methods Survey of primary trial reports, published 2014–2019, identified using an electronic search filter for pragmatic trials implemented in MEDLINE, and registered in ClinicalTrials.gov. Results Among 1988 trials, 132 (6.6%) did not include a statement about participant consent, 1691 (85.0%) reported consent had been obtained, 139 (7.0%) reported a waiver and 26 (1.3%) reported consent for one aspect (eg, data collection) but a waiver for another (eg, intervention). Of the 165 trials reporting a waiver, 76 (46.1%) provided a justification. Few (53, 2.9%) explicitly reported use of alternative approaches to consent. In multivariable logistic regression analyses, lower journal impact factor (p=0.001) and cluster randomisation (pDiscussion Not obtaining consent seems to be increasing and is associated with the use of cluster randomisation and pragmatic aims, but neither cluster randomisation nor pragmatism are currently accepted justifications for waivers of consent. Rather than considering either standard written informed consent or waivers of consent, researchers and research ethics committees could consider alternative consent approaches that may facilitate the conduct of pragmatic trials while preserving patient autonomy and the public’s trust in research.
- 15 November 2021
- Published by BMJ in Journal of Medical Ethics
- Vol. 49 (1) , 34-40
Open AccessInformed consent in pragmatic trials: results from a survey of trials published 2014–2019
Objectives To describe reporting of informed consent in pragmatic trials, justifications for waivers of consent and reporting of alternative approaches to standard written consent. To identify factors associated with (1) not reporting and (2) not obtaining consent. Methods Survey of primary trial reports, published 2014–2019, identified using an electronic search filter for pragmatic trials implemented in MEDLINE, and registered in ClinicalTrials.gov. Results Among 1988 trials, 132 (6.6%) did not include a statement about participant consent, 1691 (85.0%) reported consent had been obtained, 139 (7.0%) reported a waiver and 26 (1.3%) reported consent for one aspect (eg, data collection) but a waiver for another (eg, intervention). Of the 165 trials reporting a waiver, 76 (46.1%) provided a justification. Few (53, 2.9%) explicitly reported use of alternative approaches to consent. In multivariable logistic regression analyses, lower journal impact factor (p=0.001) and cluster randomisation (pDiscussion Not obtaining consent seems to be increasing and is associated with the use of cluster randomisation and pragmatic aims, but neither cluster randomisation nor pragmatism are currently accepted justifications for waivers of consent. Rather than considering either standard written informed consent or waivers of consent, researchers and research ethics committees could consider alternative consent approaches that may facilitate the conduct of pragmatic trials while preserving patient autonomy and the public’s trust in research.
- 1 September 2021
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 137, 45-57
A review of pragmatic trials found a high degree of diversity in design and scope, deficiencies in reporting and trial registry data, and poor indexing
- 1 September 2021
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 137, 45-57
A review of pragmatic trials found a high degree of diversity in design and scope, deficiencies in reporting and trial registry data, and poor indexing